Download PDF
CC BY-NC-ND 4.0 · Journal of Social Health and Diabetes 2016; 04(02): 133-136
DOI: 10.4103/2321-0656.187988
Original Article
NovoNordisk Education Foundation

Anxiety among patients with diabetes mellitus evaluated using generalized anxiety disorder 7-item scale

Amit Thour
Department of Medicine, Government Medical College and Hospital, Chandigarh, India
,
Ramninder Nagra
Department of Medicine, Government Medical College and Hospital, Chandigarh, India
,
Arunjeet Gosal
Department of Medicine, Government Medical College and Hospital, Chandigarh, India
,
Tejasav Sehrawat
Department of Medicine, Government Medical College and Hospital, Chandigarh, India
,
Subhash Das
1   Department of Psychiatry, Government Medical College and Hospital, Chandigarh, India
,
Yashdeep Gupta
Department of Medicine, Government Medical College and Hospital, Chandigarh, India
› Author Affiliations
Further Information

Publication History

Publication Date:
23 November 2018 (online)

Also available at
   Permissions and Reprints

Abstract

Background: Anxiety has been shown to be associated with poor outcomes in people with diabetes. However, there has been limited data, especially from India, which has specifically examined whether diabetes mellitus is associated with an increased likelihood of comorbid anxiety.

Aim: The aim was to estimate the prevalence of anxiety in patients with diabetes and to determine the association of anxiety with age, sex, and other related parameters.

Setting: Endocrine clinic, tertiary care hospital.

Design: Cross-sectional.

Materials and Methods: The study was cross-sectional carried out in endocrinology clinic of tertiary care hospital in North India. Cases were patients with type 2 diabetes mellitus above 30 years of age. Anxiety was assessed using the generalized anxiety disorders 7-item (GADs-7) scale. The relationship with a sociodemographic profile, duration of diabetes, hypertension, and microvascular complications was also analyzed.

Results: Seventy-three subjects (42.5% females) with mean age 50.8 ± 9.2 years were evaluated. The prevalence of anxiety was 34%. Severe anxiety (GAD-7 score ≥15) was present in three (4%) subjects, moderate anxiety (GAD-7 score ≥10) was present in six (8%) subjects, and mild anxiety was present in 16 (22%) of subjects. Anxiety increased with fasting plasma glucose, hypertension, was more in women, but the differences were not statistically significant.

Conclusions: Our study demonstrates a higher prevalence of anxiety in patients with type 2 diabetes. No factor was significantly associated with anxiety. Therefore, anxiety should be assessed in each and every patient, irrespective of other factors.

Diabetes mellitus - generalized anxiety disorders - generalized anxiety disorders-7 - prevalence
 

  • References

  • 1 Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2014; 103: 137-149
    CrossrefPubMedGoogle Scholar
  • 2 Lynch CP, Gebregziabher M, Zhao Y, Hunt KJ, Egede LE. Impact of medical and psychiatric multi-morbidity on mortality in diabetes: Emerging evidence. BMC Endocr Disord 2014; 14: 068
    CrossrefPubMedGoogle Scholar
  • 3 Smith KJ, Béland M, Clyde M, Gariépy G, Pagé V, Badawi G. et al. Association of diabetes with anxiety: A systematic review and meta-analysis. J Psychosom Res 2013; 74: 089-099
    CrossrefPubMedGoogle Scholar
  • 4 Chaudhry R, Mishra P, Mishra J, Parminder S, Mishra BP. Psychiatric morbidity among diabetic patients: A hospital-based study. Ind Psychiatry J 2010; 19: 047-049
    CrossrefPubMedGoogle Scholar
  • 5 Balhara YP, Sagar R. Correlates of anxiety and depression among patients with type 2 diabetes mellitus. Indian J Endocrinol Metab 2011; 15 (Suppl. 01) S50-S54
    CrossrefPubMedGoogle Scholar
  • 6 Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch Intern Med 2006; 166: 1092-1097
    CrossrefPubMedGoogle Scholar
  • 7 Kaur G, Tee GH, Ariaratnam S, Krishnapillai AS, China K. Depression, anxiety and stress symptoms among diabetics in Malaysia: A cross sectional study in an urban primary care setting. BMC Fam Pract 2013; 14: 069
    CrossrefPubMedGoogle Scholar
  • 8 Wu SF, Young LS, Yeh FC, Jian YM, Cheng KC, Lee MC. Correlations among social support, depression, and anxiety in patients with type-2 diabetes. J Nurs Res 2013; 21: 129-138
    CrossrefPubMedGoogle Scholar
  • 9 Tovilla-Zárate C, Juárez-Rojop I, Peralta Jimenez Y, Jiménez MA, Vázquez S, Bermúdez-Ocaña D. et al. Prevalence of anxiety and depression among outpatients with type 2 diabetes in the Mexican population. PLoS One 2012; 7: e36887
    CrossrefPubMedGoogle Scholar
  • 10 Thour A, Das S, Sehrawat T, Gupta Y. Depression among patients with diabetes mellitus in North India evaluated using patient health questionnaire-9. Indian J Endocrinol Metab 2015; 19: 252-255
    CrossrefPubMedGoogle Scholar
  • 11 Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: A meta-analysis. Diabetes Care 2001; 24: 1069-1078
    CrossrefPubMedGoogle Scholar
  • 12 Al Hayek AA, Robert AA, Al Dawish MA, Zamzami MM, Sam AE, Alzaid AA. Impact of an education program on patient anxiety, depression, glycemic control, and adherence to self-care and medication in type 2 diabetes. J Family Community Med 2013; 20: 077-082
    Google Scholar
  • 13 Mikaliukštiene A, Žagminas K, Juozulynas A, Narkauskaite L, Salyga J, Jankauskiene K. et al. Prevalence and determinants of anxiety and depression symptoms in patients with type 2 diabetes in Lithuania. Med Sci Monit 2014; 20: 182-190
    CrossrefPubMedGoogle Scholar